Page last updated: 2024-10-31

metyrapone and Lung Neoplasms

metyrapone has been researched along with Lung Neoplasms in 12 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Preoperative metyrapone treatment, which suppresses hypersecretion of endogenous glucocorticoids as a result of operation, modulates the enhancement of cancer metastases and may be an effective treatment."3.70Usefulness of metyrapone treatment to suppress cancer metastasis facilitated by surgical stress. ( Deguchi, M; Isobe, Y; Matsukawa, S; Nakagawara, G; Yamaguchi, A, 1998)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19907 (58.33)18.7374
1990's3 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwayama, H1
Hirase, S1
Nomura, Y1
Ito, T1
Morita, H1
Otake, K1
Okumura, A1
Takagi, J1
Aziz, SI1
Khattak, MA1
Usmani, Z1
Ladipeerla, N1
Pittman, K1
Suda, T1
Tozawa, F1
Dobashi, I1
Horiba, N1
Ohmori, N1
Yamakado, M1
Yamada, M1
Demura, H1
Deguchi, M1
Isobe, Y1
Matsukawa, S1
Yamaguchi, A1
Nakagawara, G1
Koelmeyer, TD1
Woods, WP1
Wiedemann, E1
Saito, T1
Linfoot, JA1
Li, CH1
Dimopoulos, MA1
Fernandez, JF1
Samaan, NA1
Holoye, PY1
Vassilopoulou-Sellin, R1
Steel, K1
Baerg, RD1
Adams, DO1
Coll, R1
Horner, I1
Kraiem, Z1
Gafni, J1
Brun, J1
Revol, A1
Queneau, P1
Sachs, BA1
Becker, N1
Bloomberg, AE1
Grunwald, RP1
Upton, GV1
Amatruda, TT1

Other Studies

12 other studies available for metyrapone and Lung Neoplasms

ArticleYear
Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review.
    BMC endocrine disorders, 2018, Mar-27, Volume: 18, Issue:1

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Aged; Female; Humans; Hydrocortisone; Lung Neop

2018
Metyrapone: a management option for ectopic ACTH syndrome in small cell lung cancer treated with intravenous etoposide.
    BMJ case reports, 2011, Aug-04, Volume: 2011

    Topics: ACTH Syndrome, Ectopic; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Infusions, Int

2011
Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    The Journal of clinical investigation, 1993, Volume: 92, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Arginine

1993
Usefulness of metyrapone treatment to suppress cancer metastasis facilitated by surgical stress.
    Surgery, 1998, Volume: 123, Issue:4

    Topics: Adrenalectomy; Animals; Apoptosis; Corticosterone; Female; Leukocyte Count; Lung Neoplasms; Lymphocy

1998
Carcinoma of the lung presenting as Cushing's syndrome.
    The New Zealand medical journal, 1977, Jan-12, Volume: 85, Issue:579

    Topics: Aminoglutethimide; Carcinoma, Bronchogenic; Cortisone; Cushing Syndrome; Cyclophosphamide; Diagnosis

1977
Specific radioimmunoassay of human beta-endorphin in unextracted plasma.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:3

    Topics: Adenoma; Adrenal Gland Neoplasms; Carcinoma, Bronchogenic; Cushing Syndrome; Dexamethasone; Endorphi

1979
Paraneoplastic Cushing's syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer.
    Cancer, 1992, Jan-01, Volume: 69, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Cushing Syndrome; Female; Humans; Lung Ne

1992
Cushing's syndrome in association with a carcinoid tumor of the lung.
    The Journal of clinical endocrinology and metabolism, 1967, Volume: 27, Issue:9

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Carcinoid Tumor; Cushing Sy

1967
Successful metyrapone therapy of the ectopic ACTH syndrome.
    Archives of internal medicine, 1968, Volume: 121, Issue:6

    Topics: Adolescent; Adrenocorticotropic Hormone; Biopsy; Carcinoma; Cushing Syndrome; Cyclophosphamide; Horm

1968
[Broncho-pulmonary cancer with true or degraded hypercorticism].
    La Presse medicale, 1969, Nov-29, Volume: 77, Issue:51

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocortical Hyperfunction; Adrenocorticotropic Hormon

1969
"Cure" of ectopic ACTH syndrome secondary to adrenocarcinoma of the lung.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 30, Issue:5

    Topics: 17-Ketosteroids; Acid Phosphatase; Adenocarcinoma; Adrenocorticotropic Hormone; Cushing Syndrome; Cy

1970
Evidence for the presence of tumor peptides with corticotropin-releasing-factor-like activity in the ectopic ACTH syndrome.
    The New England journal of medicine, 1971, Aug-19, Volume: 285, Issue:8

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Amino Acids; Animals; Biolo

1971